Michael Bradford
Acute Care · Shreveport, LANPI 1669151130
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.9% of the total across 234 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 19.4% — the pattern of someone who eats at a lot of different presentations.
Across 234 payments — averaging $18.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$828
- GSK$824
- Actelion Pharmaceuticals US, Inc.$547
- Boehringer Ingelheim$367
- Sanofi$241
- United Therapeutics Corporation$228
- plus $1K from 17 others
What the payments were for
- Food & beverage$4,09396%
- Education$1744%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 43 | $828 |
| GSK | 55 | $824 |
| Actelion Pharmaceuticals US, Inc. | 34 | $547 |
| Boehringer Ingelheim | 17 | $367 |
| Sanofi | 10 | $241 |
| United Therapeutics Corporation | 10 | $228 |
| Merck | 10 | $202 |
| Insmed, Inc. | 10 | $172 |
| Mallinckrodt Hospital Products Inc. | 8 | $160 |
| Baxter Healthcare | 7 | $127 |
| Regeneron Healthcare Solutions, Inc. | 4 | $104 |
| Grifols USA, LLC | 4 | $86 |
| Verona Pharma, Inc. | 4 | $76 |
| Johnson & Johnson | 4 | $57 |
| Viatris Specialty LLC | 2 | $49 |
| Electromed, Inc. | 3 | $47 |
| Paratek Pharmaceuticals, Inc. | 2 | $40 |
| Mylan Specialty L.p. | 2 | $36 |
| Ambu Inc. | 1 | $19 |
| La Jolla Pharmaceutical Company | 1 | $16 |
| 3b Medical, Inc. | 1 | $14 |
| Bayer | 1 | $14 |
| Shionogi Inc | 1 | $13 |
How this compares
$4,267 in reported general payments places this provider in the 85th percentile of 248 acute care providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 13 | $195,803 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 111 | $91,683 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 18 | $10,920 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 13 | $3,443 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 69 | $1,808 |
| BreynaBudesonide/Formoterol Fumarate | 11 | $1,690 |
| Ventolin HfaAlbuterol Sulfate | 13 | $715 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimOfev | $367 | $195,80313 claims |
| GSKTrelegy Ellipta | $824 | $91,683111 claims |
| AstraZenecaBreztri Aerosphere | $828 | $10,92018 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 248 acute care providers in Louisiana.
Other acute care in Shreveport
- Brinton FegleyShreveport$61K
- Jeremy DavisShreveport$35K
- Heather MecomShreveport$17K
- Mary HireShreveport$11K
- Sammi SmithShreveport$10K
- Heather HebertShreveport$9K
- Richard ChoateShreveport$7K
- Jennifer NinhShreveport$6K
- Laurie SimmonsShreveport$5K
- Brandy RambinShreveport$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.